These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 1978472

  • 1. A double-blind comparative multicentre study of remoxipride and haloperidol in schizophrenia.
    Lindström LH, Wieselgren IM, Struwe G, Kristjansson E, Akselson S, Arthur H, Andersen T, Lindgren S, Norman O, Naimell L.
    Acta Psychiatr Scand Suppl; 1990; 358():130-5. PubMed ID: 1978472
    [Abstract] [Full Text] [Related]

  • 2. A double-blind multicentre study comparing remoxipride, two and three times daily, with haloperidol in schizophrenia.
    Laux G, Klieser E, Schröder HG, Dittmann V, Unterweger B, Schubert H, König P, Schöny HW, Bunse J, Beckmann H.
    Acta Psychiatr Scand Suppl; 1990; 358():125-9. PubMed ID: 1978471
    [Abstract] [Full Text] [Related]

  • 3. Remoxipride and haloperidol in schizophrenia: a double-blind multicentre study.
    Ahlfors UG, Rimön R, Appelberg B, Hagert U, Harma P, Katila H, Mahlanen A, Mehtonen OP, Naukkarinen H, Outakoski J.
    Acta Psychiatr Scand Suppl; 1990; 358():99-103. PubMed ID: 1978501
    [Abstract] [Full Text] [Related]

  • 4. A double-blind multicentre study comparing remoxipride, controlled release formulation, with haloperidol in schizophrenia.
    Pflug B, Bartels M, Bauer H, Bunse J, Gallhofer B, Haas S, Kanzow WT, Klieser E, Küfferle B, Stein D.
    Acta Psychiatr Scand Suppl; 1990; 358():142-6. PubMed ID: 1978475
    [Abstract] [Full Text] [Related]

  • 5. A double blind comparative multicentre study of remoxipride and haloperidol in schizophrenia.
    Andersen J, Kørner A, Ostergaard P, Fensbo C, Birket-Smith M, Thiesen S, Hansen NR, Fogh M, Kristensen M, Møller-Nielsen EM.
    Acta Psychiatr Scand Suppl; 1990; 358():104-7. PubMed ID: 1978467
    [Abstract] [Full Text] [Related]

  • 6. A double-blind comparative study of remoxipride and haloperidol in schizophrenic and schizophreniform disorders.
    Mendlewicz J, de Bleeker E, Cosyns P, Deleu G, Lotstra F, Masson A, Mertens C, Parent M, Peuskens J, Suy E.
    Acta Psychiatr Scand Suppl; 1990; 358():138-41. PubMed ID: 1978474
    [Abstract] [Full Text] [Related]

  • 7. Remoxipride and haloperidol in the acute phase of schizophrenia: a double-blind comparison.
    Deo R, Soni S, Rastogi SC, Levine S, Plant I, Edwards JG, Mitchell M, Chanas A.
    Acta Psychiatr Scand Suppl; 1990; 358():120-4. PubMed ID: 1978470
    [Abstract] [Full Text] [Related]

  • 8. A double-blind comparative study of remoxipride and haloperidol in acute schizophrenia.
    den Boer JA, Ravelli DP, Huisman J, Ohrvik J, Verhoeven WM, Westenberg HG.
    Acta Psychiatr Scand Suppl; 1990; 358():108-10. PubMed ID: 1978468
    [Abstract] [Full Text] [Related]

  • 9. A double-blind multicentre comparison of remoxipride, at two dose levels, and haloperidol.
    Patris M, Agussol P, Alby JM, Brion S, Burnat G, Castelnau D, Deluermoz S, Dufour H, Ferreri M, Goudemand M.
    Acta Psychiatr Scand Suppl; 1990; 358():78-82. PubMed ID: 1978497
    [Abstract] [Full Text] [Related]

  • 10. A double-blind comparative multicentre study of controlled-release remoxipride, immediate-release remoxipride and haloperidol in schizophrenia.
    Hebenstreit GF, Laux G, Schubert H, Beckmann H, Amman J, Bunse J, Eikmeier G, Geretsegger C, Kanitz RD, Kanzow WT.
    Pharmacopsychiatry; 1991 Sep; 24(5):153-8. PubMed ID: 1685572
    [Abstract] [Full Text] [Related]

  • 11. Double blind comparative study of remoxipride and haloperidol in acute schizophrenic patients.
    Den Boer JA, Ravelli DP, Huisman J, Ohrvik J, Verhoeven WM, Westenberg HG.
    Psychopharmacology (Berl); 1990 Sep; 102(1):76-84. PubMed ID: 1975448
    [Abstract] [Full Text] [Related]

  • 12. Clinical profile of remoxipride--a combined analysis of a comparative double-blind multicentre trial programme.
    Lewander T, Westerbergh SE, Morrison D.
    Acta Psychiatr Scand Suppl; 1990 Sep; 358():92-8. PubMed ID: 1978500
    [Abstract] [Full Text] [Related]

  • 13. A controlled dose-ranging study of remoxipride and haloperidol in schizophrenia--a Canadian multicentre trial.
    Lapierre YD, Nair NP, Chouinard G, Awad AG, Saxena B, Jones B, McClure DJ, Bakish D, Max P, Manchanda R.
    Acta Psychiatr Scand Suppl; 1990 Sep; 358():72-7. PubMed ID: 1978496
    [Abstract] [Full Text] [Related]

  • 14. Experiences of long-term treatment with remoxipride: efficacy and tolerability.
    Wålinder J, Holm AC.
    Acta Psychiatr Scand Suppl; 1990 Sep; 358():158-63. PubMed ID: 1978477
    [Abstract] [Full Text] [Related]

  • 15. An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder.
    Goff DC, Posever T, Herz L, Simmons J, Kletti N, Lapierre K, Wilner KD, Law CG, Ko GN.
    J Clin Psychopharmacol; 1998 Aug; 18(4):296-304. PubMed ID: 9690695
    [Abstract] [Full Text] [Related]

  • 16. Atypical neuroleptics in acute schizophrenia: a double-blind comparative study of remoxipride and haloperidol.
    den Boer JA, Westenberg HG.
    Psychopharmacol Bull; 1990 Aug; 26(1):99-107. PubMed ID: 1973547
    [Abstract] [Full Text] [Related]

  • 17. A dose-finding study with remoxipride in the acute treatment of schizophrenic patients.
    Lapierre YD, Ancill R, Awad G, Bakish D, Beaudry P, Bloom D, Chandrasena R, Das M, Durand C, Elliott D.
    J Psychiatry Neurosci; 1992 Oct; 17(4):134-45. PubMed ID: 1450186
    [Abstract] [Full Text] [Related]

  • 18. Safety evaluation in both short- and long-term treatment of schizophrenia with remoxipride.
    Morrison D, Englund A, Lawrie V, Lewander T, Schlachet A, Westerbergh SE.
    Acta Psychiatr Scand Suppl; 1990 Oct; 358():164-9. PubMed ID: 1978478
    [Abstract] [Full Text] [Related]

  • 19. Cognitive disturbances in neuroleptic therapy.
    Strauss WH, Klieser E.
    Acta Psychiatr Scand Suppl; 1990 Oct; 358():56-7. PubMed ID: 1978491
    [Abstract] [Full Text] [Related]

  • 20. A double-blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia.
    McCreadie RG, Todd N, Livingston M, Eccleston D, Watt JA, Herrington RN, Tait D, Crocket G, Mitchell MJ, Huitfeldt B.
    Acta Psychiatr Scand Suppl; 1990 Oct; 358():136-7. PubMed ID: 1978473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.